NCT03102736View on ClinicalTrials.gov

Ketamine and Nitroprusside for Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 14, 2017

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
Depression
Interventions
DRUG

Placebos

Placebo saline

DRUG

Ketamine

0.5 mg/kg ketamine

DRUG

Nitroprusside

0.5 mcg/kg nitroprusside

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03102736 - Ketamine and Nitroprusside for Depression | Biotech Hunter | Biotech Hunter